Establishments or organisations applying for the authorisation referred to in Article L. 513-11-1 have premises, staff and equipment to guarantee the quality, health safety and traceability of the faeces collected, and to reduce the risks, particularly of contamination, for recipients of medicinal products containing faecal microbiota, including preparations of faecal microbiota, in accordance with the rules of good practice provided for in Article L. 513-11-2.